Lisata Therapeutics (LSTA) Current Deferred Tax Assets (2016 - 2017)
Lisata Therapeutics' Current Deferred Tax Assets history spans 6 years, with the latest figure at $3.5 million for Q1 2017.
- For Q1 2017, Current Deferred Tax Assets fell 11.23% year-over-year to $3.5 million; the TTM value through Mar 2017 reached $3.5 million, down 11.23%, while the annual FY2016 figure was $3.6 million, 23.03% up from the prior year.
- Current Deferred Tax Assets reached $3.5 million in Q1 2017 per LSTA's latest filing, down from $3.6 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $5.1 million in Q2 2016 to a low of $2.6 million in Q4 2014.
- Average Current Deferred Tax Assets over 4 years is $3.6 million, with a median of $3.6 million recorded in 2016.
- Peak YoY movement for Current Deferred Tax Assets: soared 73.19% in 2016, then dropped 11.23% in 2017.
- A 4-year view of Current Deferred Tax Assets shows it stood at $2.6 million in 2014, then rose by 13.43% to $2.9 million in 2015, then grew by 23.03% to $3.6 million in 2016, then dropped by 1.22% to $3.5 million in 2017.
- Per Business Quant, the three most recent readings for LSTA's Current Deferred Tax Assets are $3.5 million (Q1 2017), $3.6 million (Q4 2016), and $4.3 million (Q3 2016).